8-70597921-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_014294.6(TRAM1):c.400G>A(p.Val134Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000938 in 1,599,628 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_014294.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRAM1 | NM_014294.6 | c.400G>A | p.Val134Ile | missense_variant | 4/11 | ENST00000262213.7 | NP_055109.1 | |
TRAM1 | NM_001317804.2 | c.307G>A | p.Val103Ile | missense_variant | 5/12 | NP_001304733.1 | ||
TRAM1 | NM_001317805.2 | c.142G>A | p.Val48Ile | missense_variant | 4/11 | NP_001304734.1 | ||
TRAM1 | XM_047421636.1 | c.142G>A | p.Val48Ile | missense_variant | 5/12 | XP_047277592.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRAM1 | ENST00000262213.7 | c.400G>A | p.Val134Ile | missense_variant | 4/11 | 1 | NM_014294.6 | ENSP00000262213 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151990Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248452Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134350
GnomAD4 exome AF: 0.00000829 AC: 12AN: 1447638Hom.: 0 Cov.: 31 AF XY: 0.00000833 AC XY: 6AN XY: 719976
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151990Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74256
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at